Loading...
NPI 1588724108 · Pasadena, CA · Ophthalmology Physician
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Rizwan Bhatti is a ophthalmology physician provider located in Pasadena, California. This profile covers 16 Medicare and 4 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Individual |
| Organization | Rizwan Bhatti |
| Address | 10 Congress St |
| City | Pasadena |
| State | CA |
| ZIP | 91105 |
| Taxonomy | Ophthalmology Physician |
| NPI Enumerated | December 12, 2006 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $2.9M |
| Medicaid | $4.7K |
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
16 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | 1,460 | $690 | $1M |
| 92014 | An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group… | 5,320 | $110 | $569.7K |
| 67028 | The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye. | 4,090 | $100 | $409.1K |
| J2778 | Injection, ranibizumab, 0.1 mg | 1,350 | $180 | $243.4K |
| 92134 | The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes. | 4,900 | $40 | $171.6K |
| J9035 | Injection, bevacizumab, 10 mg | 2,980 | $60 | $169.6K |
| J2777 | Injection, faricimab‑svoa, 0.1 mg | 3,660 | $30 | $106.1K |
| 92004 | The provider performs a comprehensive level ophthalmological evaluation of a new patient and initiates a diagnostic and treatment program for one or more visits. | 400 | $120 | $47.9K |
| 67228 | In retinopathy, tiny new vessels grow profusely and fibrous tissue proliferates in between the layers of the retina, which may extend into the optic nerve and vitreous, clear gel that fills the space… | 150 | $300 | $44.5K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 480 | $80 | $38.4K |
Showing 1–10 of 16
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 16 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
16 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| J0178 | 70 | 310 | 570 | $690 | $647.1K |
| J2777 | 166 | 200 | 10,740 | $30 | $459.5K |
| J2778 | 35 | 130 | 700 | $180 | $196K |
| 67028 | 3 | 470 | 420 | $100 | $71.8K |
| 92014 | 2 | 2,890 | 110 | $100 | $28.7K |
| 92012 | 1,264 | 1,620 | 150 | $70 | $23.6K |
| 92235 | 42 | 270 | 60 | $110 | $17.1K |
| 99213 | 3,472 | 34,660 | 80 | $70 | $13.2K |
| 92134 | 8 | 2,150 | 90 | $30 | $12.6K |
| 92004 | 46 | 1,950 | 50 | $110 | $9.7K |
Showing 1–10 of 16
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
4 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 67028 | The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye. | 180 | $10 | $2.2K |
| J9035 | Injection, bevacizumab, 10 mg | 160 | $10 | $1.4K |
| 92014 | An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group… | 200 | $10 | $990 |
| 92134 | The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes. | 180 | $1 | $180 |
How this provider's Medicaid billing volume and revenue compare to other California providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. California median
4 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 67028 | The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye. | 243 | 360 | 840 | $160 | $495.3K |
| J9035 | Injection, bevacizumab, 10 mg | 143 | 230 | 310 | $110 | $232K |
| 92134 | The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes. | 439 | 700 | 420 | $20 | $60.3K |
| 92014 | An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group… | 1,545 | 2,460 | 430 | $30 | $48.3K |
Other providers in the same ZIP code as Rizwan Bhatti, ranked by combined Medicare and Medicaid revenue.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.